Short Interest in SARTORIUS (OTCMKTS:SARTF) Increases By 200.0%

Key Points

• Short interest in Sartorius increased by 200.0% in July, from 500 shares to 1,500 shares, suggesting growing investor bearishness.
• Jefferies Financial Group upgraded Sartorius to a "strong-buy" rating, indicating positive sentiment from analysts.
• Sartorius reported an EPS of $1.38 for the latest quarter, missing the consensus estimate of $1.49, despite having revenue that exceeded forecasts at $1.04 billion.

SARTORIUS (OTCMKTS:SARTF - Get Free Report) was the target of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 1,500 shares, anincreaseof200.0% from the July 15th total of 500 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised shares of SARTORIUS to a "strong-buy" rating in a report on Tuesday, August 12th. Three investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Strong Buy".

SARTORIUS Stock Performance

SARTORIUS stock remained flat at $190.00 during mid-day trading on Thursday. SARTORIUS has a fifty-two week low of $165.00 and a fifty-two week high of $243.35. The company has a quick ratio of 0.88, a current ratio of 1.39 and a debt-to-equity ratio of 1.08. The stock has a fifty day moving average of $193.30 and a 200 day moving average of $196.94.

SARTORIUS (OTCMKTS:SARTF - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The company reported $1.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.49 by ($0.11). SARTORIUS had a net margin of 3.00% and a return on equity of 7.79%. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $977.90 million.

About SARTORIUS

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.